Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Trading Statement

28 Apr 2009 07:00

RNS Number : 2435R
Merchant Securities PLC
28 April 2009
 



 28 April 2009 

Merchant Securities plc ("Merchant Securities" or the "Company")

Trading update

Merchant Securities, the financial services group specialising in institutional and private client stockbroking, corporate finance, corporate broking and private equity, announces a trading update for the year ended 31 March 2009.

Despite the continuing difficult market conditions, the Company's trading in the second half of the financial year ended 31 March 2009 has seen the improvement predicted by the board at the time of the interim results. 

The board, currently and subject to audit, expects to report a modest profit before tax, goodwill impairment, revaluation of investments and non-recurring items for the second six months of the year, following the loss, on the same basis, of £581,575 announced for the first half of the financial year. The board also expects revenue for the year to be similar to that generated in the year ended 31 March 2008, which was £5.3 million.

As at 31 March 2009, the Company had net tangible assets of £2.9mcash of £2.2 million and no debt.

The Company acquired John East & Partners Limited("John East & Partners") a corporate finance adviser, nominated adviser and corporate broker, in October 2007. It inow intended to merge its business with that of the Company's other operating subsidiary, Merchant Securities Group Limited, to create a single entity which will carry out all the activities currently conducted within the group. The name of the trading subsidiary will be Merchant John East Securities Limited and it is hoped to have completed the necessary restructuring by 30 September 2009.

John East & Partners was recently shortlisted for the Growth Company Investor AIM Adviser of the Year award for the sixth time in the last seven years and for the AIM Broker of the year award for the first time.  

 

Patrick Claridge, Chief Executive, Merchant Securities plc, says:

"Although trading conditions remain difficult, the second half of the year ended 31 March 2009, saw the Company return to an operating profit. The decisive action taken by the board and focus on the core objectives of the business, combined with tough cost control, have helped to return the Company to the black."

The Company expects to announce its results for the year ended 31 March 2009 by the end of July 2009.

- ends -

For further information please contact:

Patrick Claridge Chief Executive 020 7375 9010

Merchant Securities plc

Roland Cross Director 020 7726 6111

Broadgate

Richard Day Director 020 7398 1600

Arden Partners plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDSUGDGGCR
Date   Source Headline
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.